Thoracic: Lung Cancer
Predictors of survival following surgical resection of limited-stage small cell lung cancer

Read at the 100th Annual Meeting of The American Association for Thoracic Surgery: A Virtual Learning Experience, May 22-23, 2020.
https://doi.org/10.1016/j.jtcvs.2020.10.148Get rights and content
Under an Elsevier user license
open archive

Abstract

Background

Adjuvant chemotherapy, postoperative radiation (PORT), and prophylactic cranial irradiation (PCI) have been individually examined in limited-stage small cell lung cancer (SCLC). There is a paucity of data on the effectiveness of each adjuvant treatment modality when used in combination after surgical resection of SCLC.

Methods

Data were collected from 5 cancer centers on all patients with limited-stage SCLC who underwent surgical resection between 1986 and 2019. Univariate and multivariable models were conducted to identify predictors of long-term outcomes, focusing on freedom from recurrence and survival benefit of adjuvant chemotherapy, PORT, and PCI.

Results

A total of 164 patients were analyzed. Multivariable Cox regression analysis did not identify any adjuvant therapies to significantly influence recurrence in this cohort. Specifically, PORT was not associated with a significant influence on locoregional recurrence and PCI was not significantly associated with intracranial outcomes. Adjuvant chemotherapy improved survival in all stage I through III disease (hazard ratio, 0.49; 95% confidence interval, 0.29-0.81; P = .005) and even in pathologically node negative patients (hazard ratio, 0.49; 95% confidence interval, 0.27-0.91; P = .024). Although PCI was found to improve survival in univariate analysis, it was not significant in a multivariable model. PORT was not found to affect survival on either univariate or multivariable analysis.

Conclusions

This is among the largest multi-institutional studies on surgically resected limited-stage SCLC. Our results highlight survival benefit of adjuvant chemotherapy, but did not identify a statistically significant influence from mediastinal PORT or PCI in our cohort. Larger prospective studies are needed to determine the benefit of PORT or PCI in a surgically resected limited-stage SCLC population.

Key Words

small cell lung cancer
adjuvant chemotherapy
adjuvant radiation
prophylactic
cranial irradiation

Abbreviations and Acronyms

FFR
freedom from recurrence
SCLC
small cell lung cancer
PCI
prophylactic cranial irradiation
PORT
postoperative radiation therapy
OS
overall survival
RFS
recurrence-free survival
LRR
locoregional recurrence

Cited by (0)

Funding provided by generous philanthropic donations from the Mason Family Research Fund.

Members of the Small Cell Lung Cancer Working Group are listed in the Acknowledgments.